APO Research
Talk to an analyst

APO RESEARCH · REPORT

Luseogliflozin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Luseogliflozin Industry Growth and Trends Forecast to 2032

19 December 202577 pages

Choose your research edition.

Industry ResearchLuseogliflozin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Luseogliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Luseogliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Luseogliflozin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Luseogliflozin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Luseogliflozin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Luseogliflozin include Taisho Toyama, Novartis, Mitsubishi Tanabe Pharma and CR Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Luseogliflozin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Luseogliflozin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Luseogliflozin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Luseogliflozin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Luseogliflozin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Luseogliflozin Market by Company

Taisho Toyama

Novartis

Mitsubishi Tanabe Pharma

CR Double-Crane

Luseogliflozin Segment by Type

2.5mg

5mg

Luseogliflozin Segment by Application

Periodontitis

Heart Disease

Diabetes

Luseogliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Luseogliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Luseogliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Luseogliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Luseogliflozin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Luseogliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5mg Table 2. Major Company of 5mg Table 3. Global Luseogliflozin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 5. Global Luseogliflozin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Luseogliflozin Sales Market Share in Value by Type (2021-2026) Table 8. Global Luseogliflozin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 10. Global Luseogliflozin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Luseogliflozin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Luseogliflozin Sales Market Share in Value by Type (2027-2032) Table 13. Global Luseogliflozin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 15. North America Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 17. Europe Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Luseogliflozin Sales by Type (2021-2026) & (US$ Million) Table 24. Luseogliflozin Industry Trends Table 25. Luseogliflozin Industry Drivers Table 26. Luseogliflozin Industry Opportunities and Challenges Table 27. Luseogliflozin Industry Restraints Table 28. Global Luseogliflozin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Luseogliflozin Revenue Market Share by Company (2021-2026) Table 30. Global Luseogliflozin Sales by Company (2021-2026) & (K Units) Table 31. Global Luseogliflozin Sales Share by Company (2021-2026) Table 32. Global Luseogliflozin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Luseogliflozin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Luseogliflozin Major Company Production Sites and Headquarters Table 35. Global Luseogliflozin Company, Product Type & Application Table 36. Global Luseogliflozin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Luseogliflozin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Luseogliflozin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Luseogliflozin Sales by Region (2021-2026) & (K Units) Table 41. Global Luseogliflozin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Luseogliflozin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Luseogliflozin Sales Market Share in Value by Region (2021-2026) Table 44. Global Luseogliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Luseogliflozin Sales by Region (2027-2032) & (K Units) Table 46. Global Luseogliflozin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Luseogliflozin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Luseogliflozin Sales Market Share in Value by Region (2027-2032) Table 49. Global Luseogliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Luseogliflozin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 52. Global Luseogliflozin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Luseogliflozin Sales Market Share in Value by Application (2021-2026) Table 55. Global Luseogliflozin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 57. Global Luseogliflozin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Luseogliflozin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Luseogliflozin Sales Market Share in Value by Application (2027-2032) Table 60. Global Luseogliflozin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 62. North America Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 64. Europe Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Luseogliflozin Sales by Application (2021-2026) & (US$ Million) Table 71. Taisho Toyama Company Information Table 72. Taisho Toyama Business Overview Table 73. Taisho Toyama Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Taisho Toyama Luseogliflozin Product Portfolio Table 75. Taisho Toyama Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis Luseogliflozin Product Portfolio Table 80. Novartis Recent Development Table 81. Mitsubishi Tanabe Pharma Company Information Table 82. Mitsubishi Tanabe Pharma Business Overview Table 83. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio Table 85. Mitsubishi Tanabe Pharma Recent Development Table 86. CR Double-Crane Company Information Table 87. CR Double-Crane Business Overview Table 88. CR Double-Crane Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CR Double-Crane Luseogliflozin Product Portfolio Table 90. CR Double-Crane Recent Development Table 91. North America Luseogliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 93. North America Luseogliflozin Sales Market Share by Country (2021-2026) Table 94. North America Luseogliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Luseogliflozin Sales Market Share Forecast by Country (2027-2032) Table 96. North America Luseogliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Luseogliflozin Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Luseogliflozin Market Share by Country (2021-2026) Table 99. North America Luseogliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Luseogliflozin Market Share Forecast by Country (2027-2032) Table 101. Europe Luseogliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 103. Europe Luseogliflozin Sales Market Share by Country (2021-2026) Table 104. Europe Luseogliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Luseogliflozin Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Luseogliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Luseogliflozin Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Luseogliflozin Market Share by Country (2021-2026) Table 109. Europe Luseogliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Luseogliflozin Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Luseogliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Luseogliflozin Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Luseogliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Luseogliflozin Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Luseogliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Luseogliflozin Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Luseogliflozin Market Share by Country (2021-2026) Table 119. Asia-Pacific Luseogliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Luseogliflozin Market Share Forecast by Country (2027-2032) Table 121. Latin America Luseogliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 123. Latin America Luseogliflozin Sales Market Share by Country (2021-2026) Table 124. Latin America Luseogliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Luseogliflozin Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Luseogliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Luseogliflozin Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Luseogliflozin Market Share by Country (2021-2026) Table 129. Latin America Luseogliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Luseogliflozin Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Luseogliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Luseogliflozin Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Luseogliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Luseogliflozin Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Luseogliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Luseogliflozin Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Luseogliflozin Market Share by Country (2021-2026) Table 139. Middle East and Africa Luseogliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Luseogliflozin Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Luseogliflozin Distributors List Table 144. Luseogliflozin Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Luseogliflozin Image Figure 2. Global Luseogliflozin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Luseogliflozin Market Size (2021-2032) & (US$ Million) Figure 4. Global Luseogliflozin Sales (2021-2032) & (K Units) Figure 5. 2.5mg Image Figure 6. Global 2.5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg Image Figure 8. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Luseogliflozin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Luseogliflozin Market Share by Type 2025 VS 2032 Figure 11. North America Luseogliflozin Sales Market Share in Volume by Type in 2025 Figure 12. North America Luseogliflozin Sales Market Share in Value by Type in 2025 Figure 13. Europe Luseogliflozin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Luseogliflozin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Luseogliflozin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Luseogliflozin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Luseogliflozin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Luseogliflozin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Luseogliflozin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Luseogliflozin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Luseogliflozin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Periodontitis Image Figure 24. Global Periodontitis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Heart Disease Image Figure 26. Global Heart Disease Sales YoY Growth (2021-2032) & (K Units) Figure 27. Diabetes Image Figure 28. Global Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Luseogliflozin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Luseogliflozin Market Share by Application 2025 VS 2032 Figure 31. North America Luseogliflozin Sales Market Share in Volume by Application in 2025 Figure 32. North America Luseogliflozin Sales Market Share in Value by Application in 2025 Figure 33. Europe Luseogliflozin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Luseogliflozin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Luseogliflozin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Luseogliflozin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Luseogliflozin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Luseogliflozin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Luseogliflozin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Luseogliflozin Sales Market Share in Value by Application in 2025 Figure 41. North America Luseogliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Luseogliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Luseogliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Luseogliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Luseogliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Luseogliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Luseogliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Luseogliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Luseogliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Luseogliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Luseogliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Luseogliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Luseogliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Luseogliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Luseogliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Luseogliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Luseogliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Luseogliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Luseogliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Luseogliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Luseogliflozin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Luseogliflozin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg
  • 5mg
Applications
  • Periodontitis
  • Heart Disease
  • Diabetes
Companies covered
  • Taisho Toyama
  • Novartis
  • Mitsubishi Tanabe Pharma
  • CR Double-Crane

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Luseogliflozin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Luseogliflozin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Luseogliflozin Market by Type
  6. 1.3.1 2.5mg
  7. 1.3.2 5mg
  8. 1.4 Global Luseogliflozin Market Size by Type
  9. 1.4.1 Global Luseogliflozin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Luseogliflozin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Luseogliflozin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Luseogliflozin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Luseogliflozin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Luseogliflozin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Luseogliflozin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Luseogliflozin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Luseogliflozin Industry Trends
  2. 2.2 Luseogliflozin Industry Drivers
  3. 2.3 Luseogliflozin Industry Opportunities and Challenges
  4. 2.4 Luseogliflozin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Luseogliflozin Revenue (2021-2026)
  2. 3.2 Global Top Players by Luseogliflozin Sales (2021-2026)
  3. 3.3 Global Top Players by Luseogliflozin Price (2021-2026)
  4. 3.4 Global Luseogliflozin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Luseogliflozin Major Company Production Sites & Headquarters
  6. 3.6 Global Luseogliflozin Company, Product Type & Application
  7. 3.7 Global Luseogliflozin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Luseogliflozin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Luseogliflozin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Luseogliflozin Tier 1, Tier 2, and Tier 3
4 Luseogliflozin Regional Status and Outlook
  1. 4.1 Global Luseogliflozin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Luseogliflozin Historic Market Size by Region
  3. 4.2.1 Global Luseogliflozin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Luseogliflozin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Luseogliflozin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Luseogliflozin Forecasted Market Size by Region
  7. 4.3.1 Global Luseogliflozin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Luseogliflozin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Luseogliflozin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Luseogliflozin by Application
  1. 5.1 Luseogliflozin Market by Application
  2. 5.1.1 Periodontitis
  3. 5.1.2 Heart Disease
  4. 5.1.3 Diabetes
  5. 5.2 Global Luseogliflozin Market Size by Application
  6. 5.2.1 Global Luseogliflozin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Luseogliflozin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Luseogliflozin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Luseogliflozin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Luseogliflozin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Luseogliflozin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Luseogliflozin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Luseogliflozin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taisho Toyama
  2. 6.1.1 Taisho Toyama Company Information
  3. 6.1.2 Taisho Toyama Business Overview
  4. 6.1.3 Taisho Toyama Luseogliflozin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taisho Toyama Luseogliflozin Product Portfolio
  6. 6.1.5 Taisho Toyama Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Luseogliflozin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Luseogliflozin Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mitsubishi Tanabe Pharma
  14. 6.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 6.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 6.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio
  18. 6.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 6.4 CR Double-Crane
  20. 6.4.1 CR Double-Crane Company Information
  21. 6.4.2 CR Double-Crane Business Overview
  22. 6.4.3 CR Double-Crane Luseogliflozin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CR Double-Crane Luseogliflozin Product Portfolio
  24. 6.4.5 CR Double-Crane Recent Developments
7 North America by Country
  1. 7.1 North America Luseogliflozin Sales by Country
  2. 7.1.1 North America Luseogliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Luseogliflozin Sales by Country (2021-2026)
  4. 7.1.3 North America Luseogliflozin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Luseogliflozin Market Size by Country
  6. 7.2.1 North America Luseogliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Luseogliflozin Market Size by Country (2021-2026)
  8. 7.2.3 North America Luseogliflozin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Luseogliflozin Sales by Country
  2. 8.1.1 Europe Luseogliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Luseogliflozin Sales by Country (2021-2026)
  4. 8.1.3 Europe Luseogliflozin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Luseogliflozin Market Size by Country
  6. 8.2.1 Europe Luseogliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Luseogliflozin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Luseogliflozin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Luseogliflozin Sales by Country
  2. 9.1.1 Asia-Pacific Luseogliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Luseogliflozin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Luseogliflozin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Luseogliflozin Market Size by Country
  6. 9.2.1 Asia-Pacific Luseogliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Luseogliflozin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Luseogliflozin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Luseogliflozin Sales by Country
  2. 10.1.1 South America Luseogliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Luseogliflozin Sales by Country (2021-2026)
  4. 10.1.3 South America Luseogliflozin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Luseogliflozin Market Size by Country
  6. 10.2.1 South America Luseogliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Luseogliflozin Market Size by Country (2021-2026)
  8. 10.2.3 South America Luseogliflozin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Luseogliflozin Sales by Country
  2. 11.1.1 Middle East and Africa Luseogliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Luseogliflozin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Luseogliflozin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Luseogliflozin Market Size by Country
  6. 11.2.1 Middle East and Africa Luseogliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Luseogliflozin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Luseogliflozin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Luseogliflozin Value Chain Analysis
  2. 12.1.1 Luseogliflozin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Luseogliflozin Production Mode & Process
  7. 12.2 Luseogliflozin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Luseogliflozin Distributors
  10. 12.2.3 Luseogliflozin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst